vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and 908 Devices Inc. (MASS). Click either name above to swap in a different company.

Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $17.4M, roughly 1.6× 908 Devices Inc.). 908 Devices Inc. runs the higher net margin — 24.0% vs -125.8%, a 149.8% gap on every dollar of revenue. On growth, 908 Devices Inc. posted the faster year-over-year revenue change (21.2% vs 3.6%). Over the past eight quarters, 908 Devices Inc.'s revenue compounded faster (53.0% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

CMCT vs MASS — Head-to-Head

Bigger by revenue
CMCT
CMCT
1.6× larger
CMCT
$28.5M
$17.4M
MASS
Growing faster (revenue YoY)
MASS
MASS
+17.6% gap
MASS
21.2%
3.6%
CMCT
Higher net margin
MASS
MASS
149.8% more per $
MASS
24.0%
-125.8%
CMCT
Faster 2-yr revenue CAGR
MASS
MASS
Annualised
MASS
53.0%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
MASS
MASS
Revenue
$28.5M
$17.4M
Net Profit
$-11.4M
$4.2M
Gross Margin
52.7%
Operating Margin
-125.6%
17.8%
Net Margin
-125.8%
24.0%
Revenue YoY
3.6%
21.2%
Net Profit YoY
-11.4%
121.5%
EPS (diluted)
$-3.89
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
MASS
MASS
Q4 25
$28.5M
$17.4M
Q3 25
$26.2M
$14.0M
Q2 25
$29.7M
$13.0M
Q1 25
$32.3M
$11.8M
Q4 24
$27.5M
$14.3M
Q3 24
$28.6M
$14.5M
Q2 24
$34.4M
$11.5M
Q1 24
$34.0M
$7.4M
Net Profit
CMCT
CMCT
MASS
MASS
Q4 25
$-11.4M
$4.2M
Q3 25
$-12.5M
$-15.0M
Q2 25
$-9.0M
$-13.3M
Q1 25
$-6.1M
$43.6M
Q4 24
$-10.3M
$-19.4M
Q3 24
$-10.4M
$-29.3M
Q2 24
$-796.0K
$-12.5M
Q1 24
$-3.7M
$-10.9M
Gross Margin
CMCT
CMCT
MASS
MASS
Q4 25
52.7%
Q3 25
52.5%
Q2 25
48.9%
Q1 25
47.0%
Q4 24
46.5%
Q3 24
53.6%
Q2 24
53.8%
Q1 24
52.4%
Operating Margin
CMCT
CMCT
MASS
MASS
Q4 25
-125.6%
17.8%
Q3 25
-47.7%
-116.6%
Q2 25
-30.3%
-116.3%
Q1 25
-19.0%
-93.6%
Q4 24
-128.8%
-116.8%
Q3 24
-36.9%
-168.7%
Q2 24
-1.6%
-74.5%
Q1 24
-10.7%
-102.5%
Net Margin
CMCT
CMCT
MASS
MASS
Q4 25
-125.8%
24.0%
Q3 25
-47.5%
-107.0%
Q2 25
-30.3%
-102.1%
Q1 25
-18.9%
370.2%
Q4 24
-129.8%
-135.6%
Q3 24
-36.3%
-201.8%
Q2 24
-2.3%
-109.5%
Q1 24
-11.0%
-147.1%
EPS (diluted)
CMCT
CMCT
MASS
MASS
Q4 25
$-3.89
$0.09
Q3 25
$-23.52
$-0.41
Q2 25
$-18.94
$-0.37
Q1 25
$-20.73
$1.23
Q4 24
$97.71
$-0.58
Q3 24
$-305.04
$-0.84
Q2 24
$-98.64
$-0.37
Q1 24
$-125.46
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
MASS
MASS
Cash + ST InvestmentsLiquidity on hand
$15.4M
$113.0M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$143.7M
Total Assets
$859.2M
$190.1M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
MASS
MASS
Q4 25
$15.4M
$113.0M
Q3 25
$17.3M
$112.1M
Q2 25
$27.8M
$118.6M
Q1 25
$19.8M
$124.3M
Q4 24
$20.3M
$69.6M
Q3 24
$18.5M
$71.7M
Q2 24
$29.3M
$77.4M
Q1 24
$21.3M
$134.2M
Total Debt
CMCT
CMCT
MASS
MASS
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
MASS
MASS
Q4 25
$265.4M
$143.7M
Q3 25
$281.9M
$136.3M
Q2 25
$287.1M
$148.8M
Q1 25
$293.0M
$159.4M
Q4 24
$304.5M
$114.6M
Q3 24
$321.0M
$131.0M
Q2 24
$351.1M
$156.4M
Q1 24
$369.9M
$156.9M
Total Assets
CMCT
CMCT
MASS
MASS
Q4 25
$859.2M
$190.1M
Q3 25
$871.8M
$190.9M
Q2 25
$885.0M
$191.7M
Q1 25
$882.3M
$196.0M
Q4 24
$889.6M
$159.5M
Q3 24
$868.0M
$178.3M
Q2 24
$891.2M
$208.8M
Q1 24
$887.5M
$189.8M
Debt / Equity
CMCT
CMCT
MASS
MASS
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
MASS
MASS
Operating Cash FlowLast quarter
$5.8M
$1.3M
Free Cash FlowOCF − Capex
$1.3M
FCF MarginFCF / Revenue
7.6%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$-24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
MASS
MASS
Q4 25
$5.8M
$1.3M
Q3 25
$3.7M
$-4.2M
Q2 25
$-2.5M
$-5.8M
Q1 25
$1.2M
$-15.0M
Q4 24
$17.0M
$-2.2M
Q3 24
$10.3M
$-5.6M
Q2 24
$3.9M
$-13.0M
Q1 24
$1.6M
$-9.4M
Free Cash Flow
CMCT
CMCT
MASS
MASS
Q4 25
$1.3M
Q3 25
$-4.9M
Q2 25
$-5.9M
Q1 25
$-15.2M
Q4 24
$-2.4M
Q3 24
$-5.8M
Q2 24
$-13.7M
Q1 24
$-10.3M
FCF Margin
CMCT
CMCT
MASS
MASS
Q4 25
7.6%
Q3 25
-34.9%
Q2 25
-45.3%
Q1 25
-128.9%
Q4 24
-17.0%
Q3 24
-39.7%
Q2 24
-119.4%
Q1 24
-138.2%
Capex Intensity
CMCT
CMCT
MASS
MASS
Q4 25
0.0%
Q3 25
4.9%
Q2 25
0.9%
Q1 25
1.4%
Q4 24
1.3%
Q3 24
1.1%
Q2 24
5.6%
Q1 24
12.2%
Cash Conversion
CMCT
CMCT
MASS
MASS
Q4 25
0.32×
Q3 25
Q2 25
Q1 25
-0.34×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCT
CMCT

Segment breakdown not available.

MASS
MASS

Products$14.3M82%
Services$3.0M18%

Related Comparisons